OpenEvidence hits $12B valuation, with new round led by Thrive, DST  

In Brief

VCs who person backed OpenEvidence are seemingly not disquieted astir OpenAI and Anthropic’s caller wellness accusation products. 

On Wednesday, the startup announced that it raised an further $250 cardinal successful Series D backing astatine a $12 cardinal valuation, co-led by Thrive Capital and DST.  

That’s treble the valuation from its past rise successful October: $200 cardinal astatine $6 billion, led by GV. It has present raised a full of $700 million, the institution says, from backers including Sequoia, Nvidia, Kleiner Perkins, Blackstone, Bond, Craft Ventures, Mayo Clinic, and others. 

OpenEvidence is an AI-powered aesculapian accusation platform, akin to what WebMD was for the erstwhile net generation, but it’s geared toward doctors. This puts it somewhat much successful contention with Anthropic’s Claude for Healthcare, which is intended for patients, payers and providers, whereas ChatGPT’s caller wellness product is aimed much astatine consumers.

The institution says that the free, ad-supported level served 18 cardinal objective consultations from verified healthcare professionals successful the U.S. successful December alone. That compares to astir 3 cardinal searches per period a twelvemonth ago.  It besides said that it had surpassed $100 cardinal successful revenue. 

Subscribe for the industry’s biggest tech news